JP2013541583A - 組み合わせ組成物 - Google Patents

組み合わせ組成物 Download PDF

Info

Publication number
JP2013541583A
JP2013541583A JP2013537631A JP2013537631A JP2013541583A JP 2013541583 A JP2013541583 A JP 2013541583A JP 2013537631 A JP2013537631 A JP 2013537631A JP 2013537631 A JP2013537631 A JP 2013537631A JP 2013541583 A JP2013541583 A JP 2013541583A
Authority
JP
Japan
Prior art keywords
ibuprofen
paracetamol
combination
composition
hours
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2013537631A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013541583A5 (enExample
Inventor
アトキンソン，ハートレー，キャンベル
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AFT Pharmaceuticals Ltd
Original Assignee
AFT Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=46024668&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=JP2013541583(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by AFT Pharmaceuticals Ltd filed Critical AFT Pharmaceuticals Ltd
Publication of JP2013541583A publication Critical patent/JP2013541583A/ja
Publication of JP2013541583A5 publication Critical patent/JP2013541583A5/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Rheumatology (AREA)
  • Anesthesiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
JP2013537631A 2010-11-04 2011-10-26 組み合わせ組成物 Pending JP2013541583A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
NZ58901110 2010-11-04
NZ589011 2010-11-04
PCT/NZ2011/000226 WO2012060719A1 (en) 2010-11-04 2011-10-26 A combination composition

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2017055893A Division JP6353577B2 (ja) 2010-11-04 2017-03-22 組み合わせ組成物

Publications (2)

Publication Number Publication Date
JP2013541583A true JP2013541583A (ja) 2013-11-14
JP2013541583A5 JP2013541583A5 (enExample) 2014-10-09

Family

ID=46024668

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2013537631A Pending JP2013541583A (ja) 2010-11-04 2011-10-26 組み合わせ組成物
JP2017055893A Active JP6353577B2 (ja) 2010-11-04 2017-03-22 組み合わせ組成物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2017055893A Active JP6353577B2 (ja) 2010-11-04 2017-03-22 組み合わせ組成物

Country Status (28)

Country Link
US (6) US20130225685A1 (enExample)
EP (1) EP2635269B1 (enExample)
JP (2) JP2013541583A (enExample)
KR (1) KR101900520B1 (enExample)
CN (2) CN107519159A (enExample)
AU (1) AU2011324137B2 (enExample)
BR (1) BR112013010829B8 (enExample)
CA (1) CA2814057C (enExample)
CL (1) CL2013001250A1 (enExample)
CO (1) CO6771406A2 (enExample)
CY (1) CY1123398T1 (enExample)
DK (1) DK2635269T3 (enExample)
ES (1) ES2742373T3 (enExample)
HR (1) HRP20191489T1 (enExample)
HU (1) HUE045442T2 (enExample)
LT (1) LT2635269T (enExample)
MX (2) MX367209B (enExample)
MY (1) MY160572A (enExample)
NZ (1) NZ609727A (enExample)
PH (2) PH12013500689A1 (enExample)
PL (1) PL2635269T3 (enExample)
PT (1) PT2635269T (enExample)
RS (1) RS59258B1 (enExample)
RU (2) RU2707089C2 (enExample)
SG (1) SG189319A1 (enExample)
SI (1) SI2635269T1 (enExample)
SM (1) SMT201900481T1 (enExample)
WO (1) WO2012060719A1 (enExample)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2017522382A (ja) * 2014-07-18 2017-08-10 エバーブライト ファーマシューティカルズ エス．エー．アール．エル． パラセタモール及びイブプロフェンを含む水性配合物
US11413241B2 (en) 2017-04-20 2022-08-16 Hyloris Developments Sa Method for preparing a composition with a low dissolved oxygen content, comprising acetaminophen, and optionally one or more NSAIDs, and a composition obtained thereof

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2742373T3 (es) 2010-11-04 2020-02-14 Aft Pharmaceuticals Ltd Una composición de combinación
US9072710B2 (en) 2012-03-16 2015-07-07 Cumberland Pharmaceuticals Inc. Injectable ibuprofen formulation
CN106999454A (zh) * 2014-10-06 2017-08-01 坎伯兰医药品股份有限公司 共同施用静脉内布洛芬和对乙酰氨基酚以治疗疼痛
EP4480495A3 (en) * 2017-07-10 2025-06-18 Gel Cap Technologies, LLC Dual release dosage form capsule and methods, devices and systems for making same
US11197830B2 (en) 2019-02-27 2021-12-14 Aft Pharmaceuticals Limited Pharmaceutical composition containing acetaminophen and ibuprofen
US11568752B2 (en) * 2020-01-28 2023-01-31 David Clark Company Incorporated Gateway retrieval alert device for aircraft pushback operations
WO2023281089A2 (en) 2021-07-08 2023-01-12 Krka, D.D., Novo Mesto Pharmaceutical composition comprising naproxen and paracetamol
GR1010769B (el) * 2023-07-27 2024-09-18 Ιουλια Κλεωνος Τσετη Υδατικο διαλυμα ιβουπροφαινης για χρηση σε ενδοφλεβια χορηγηση
IL324832A (en) 2023-06-02 2026-01-01 Ioulia Tseti Pharmaceutical composition comprising ibuprofen
GR1010809B (el) * 2023-09-13 2024-10-25 Ιουλια Τσετη Υδατικο διαλυμα ιβουπροφαινης παρακεταμολης για χρηση σε ενδοφλεβια χορηγηση

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20060072839A (ko) * 2004-12-23 2006-06-28 김경태 아세트아미노펜과 이부프로펜을 이용하여 통증조절과 해열작용을 하는 주사제
JP2008505889A (ja) * 2004-07-07 2008-02-28 エイ・エフ・ティ・ファーマスーティカルズ・リミテッド 複合剤組成物

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997020551A1 (en) * 1995-12-05 1997-06-12 Adcock Ingram Limited Pharmaceutical composition comprising a skeletal muscle relaxant, a non-steroidal antiinflammatory agent and an analgesic
JP5185488B2 (ja) * 2001-11-02 2013-04-17 カンバーランド ファーマシューティカルズ，インコーポレーテッド ２−（４−イソブチルフェニル）プロピオン酸の医薬組成物
KR101113005B1 (ko) * 2003-03-21 2012-02-24 맥네일-피피씨, 인코포레이티드 비-스테로이드계 항염증성 약물 투여법
US7934627B2 (en) * 2005-10-13 2011-05-03 Alcoa Inc. Apparatus and method for high pressure extrusion with molten aluminum
ES2651444T3 (es) * 2006-10-20 2018-01-26 Johnson & Johnson Consumer Inc. Combinación de acetaminofeno con ibuprofeno para el tratamiento del dolor
WO2008079818A2 (en) * 2006-12-21 2008-07-03 Soluprin Pharmaceuticals, Inc. Intravenous administration of water soluble analgesic formulations
US20090264530A1 (en) * 2008-04-16 2009-10-22 Nickell Robert P Combined nsaid and acetaminophen formulation and method
TR201906742T4 (tr) * 2008-10-14 2019-05-21 Aft Pharmaceuticals Ltd Tıbbi bir ürün ve tedavi.
AU2010224063B2 (en) * 2009-03-12 2015-04-16 Cumberland Pharmaceuticals Inc Administration of intravenous ibuprofen
NZ604009A (en) * 2010-07-07 2015-03-27 Aft Pharmaceuticals Ltd A combination composition comprising ibuprofen and paracetamol
ES2742373T3 (es) 2010-11-04 2020-02-14 Aft Pharmaceuticals Ltd Una composición de combinación
CN106999454A (zh) * 2014-10-06 2017-08-01 坎伯兰医药品股份有限公司 共同施用静脉内布洛芬和对乙酰氨基酚以治疗疼痛

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008505889A (ja) * 2004-07-07 2008-02-28 エイ・エフ・ティ・ファーマスーティカルズ・リミテッド 複合剤組成物
KR20060072839A (ko) * 2004-12-23 2006-06-28 김경태 아세트아미노펜과 이부프로펜을 이용하여 통증조절과 해열작용을 하는 주사제

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
JPN6015028855; ＳＣＣＭ：　ＩＶ　Ｉｂｕｐｒｏｆｅｎ　Ｃｏｎｔｒｏｌｓ　Ｆｅｖｅｒ　ｉｎ　Ｃｒｉｔｉｃａｌｌｙ　Ｉｌｌ　Ｐａｔｉｅｎｔｓ , 20090207 *

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2017522382A (ja) * 2014-07-18 2017-08-10 エバーブライト ファーマシューティカルズ エス．エー．アール．エル． パラセタモール及びイブプロフェンを含む水性配合物
JP2020059740A (ja) * 2014-07-18 2020-04-16 エバーブライト ファーマシューティカルズ エス．エー．アール．エル． パラセタモール及びイブプロフェンを含む水性配合物
US11213498B2 (en) 2014-07-18 2022-01-04 Hyloris Pharmaceuticals S.A. Aqueous formulation comprising paracetamol and ibuprofen
US11219609B2 (en) 2014-07-18 2022-01-11 Hyloris Pharmaceuticals SA Aqueous formulation comprising paracetamol and ibuprofen
US11389416B2 (en) 2014-07-18 2022-07-19 Hyloris Pharmaceuticals SA Aqueous formulation comprising paracetamol and ibuprofen
US12083087B2 (en) 2014-07-18 2024-09-10 Hyloris Pharmaceuticals SA Aqueous formulation comprising paracetamol and ibuprofen
US11413241B2 (en) 2017-04-20 2022-08-16 Hyloris Developments Sa Method for preparing a composition with a low dissolved oxygen content, comprising acetaminophen, and optionally one or more NSAIDs, and a composition obtained thereof

Also Published As

Publication number Publication date
US20160235695A1 (en) 2016-08-18
LT2635269T (lt) 2019-09-10
PH12013500689A1 (en) 2013-05-27
KR101900520B1 (ko) 2018-09-19
US11896567B2 (en) 2024-02-13
PT2635269T (pt) 2019-09-04
CA2814057A1 (en) 2012-05-10
MX2013005113A (es) 2013-06-03
EP2635269B1 (en) 2019-05-22
HUE045442T2 (hu) 2019-12-30
US20250134839A1 (en) 2025-05-01
MX367209B (es) 2019-07-22
JP6353577B2 (ja) 2018-07-04
PH12021550804A1 (en) 2022-02-14
ES2742373T3 (es) 2020-02-14
SMT201900481T1 (it) 2019-11-13
BR112013010829A2 (pt) 2016-08-16
US20190029982A1 (en) 2019-01-31
RU2707089C2 (ru) 2019-11-22
AU2011324137A1 (en) 2013-05-02
US20240207210A1 (en) 2024-06-27
CY1123398T1 (el) 2021-10-29
RU2015103107A (ru) 2015-06-20
CN107519159A (zh) 2017-12-29
US11446266B2 (en) 2022-09-20
PL2635269T3 (pl) 2019-11-29
RU2013123646A (ru) 2014-12-10
HRP20191489T1 (hr) 2019-11-15
BR112013010829B1 (pt) 2021-12-21
CL2013001250A1 (es) 2013-08-30
EP2635269A4 (en) 2014-09-17
RS59258B1 (sr) 2019-10-31
US20130225685A1 (en) 2013-08-29
JP2017132791A (ja) 2017-08-03
KR20140025314A (ko) 2014-03-04
AU2011324137B2 (en) 2015-05-07
CA2814057C (en) 2022-02-01
DK2635269T3 (da) 2019-08-26
NZ609727A (en) 2015-07-31
US12220392B2 (en) 2025-02-11
SI2635269T1 (sl) 2019-10-30
CO6771406A2 (es) 2013-10-15
WO2012060719A1 (en) 2012-05-10
SG189319A1 (en) 2013-05-31
CN103298464A (zh) 2013-09-11
EP2635269A1 (en) 2013-09-11
US20230000805A1 (en) 2023-01-05
RU2015103107A3 (enExample) 2018-08-20
MY160572A (en) 2017-03-15
BR112013010829B8 (pt) 2022-01-04

Similar Documents

Publication Publication Date Title
JP6353577B2 (ja) 組み合わせ組成物
JP2018197248A (ja) 低減された投与容量を必要とする患者におけるベンダムスチン応答性症状の治療方法
RU2552345C2 (ru) Лекарственная форма для чресслизистого перорального введения анальгетических и/или антиспазматических молекул
KR20160033796A (ko) 저 복용량의 디클로페낙 및 베타-사이클로덱스트린 제형
RU2010132580A (ru) Способы и составы для лечения субарахноидального кровоизлияния коронарной и артериальной аневризмы
KR20170066549A (ko) 통증 치료를 위한 이부프로펜과 아세트아미노펜의 공동 정맥 투여
AU2011274652B2 (en) A combination composition comprising ibuprofen and paracetamol
CN108430581A (zh) 用于利扎曲普坦的药物组合物
JP5435659B2 (ja) トリプタンの経口腔粘膜投与用製剤形態
ES2668943T3 (es) Composición farmacéutica para tratar eyaculación precoz y método de tratamiento de la eyaculación precoz
KR20120089444A (ko) 정맥내 이부프로펜에 의한 위독한 환자의 치료방법
JP2012525359A (ja) イブプロフェンリシナートの経口投与用の懸濁液
JP2019001830A (ja) 医薬
TW200838534A (en) Treatment for irritable bowel syndrome
JPS5920221A (ja) レイノ−症状の改善・治療剤
WO2011000563A4 (en) Eltoprazine for the treatment of weight disorders

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20140822

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20140822

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20150721

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20151021

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20151124

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20151214

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20160426

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20161122